SYCP2 and neoplasm: Results showed that patients with high-SYCP2 expression had a significantly lower ESTIMATE score (p < 0.001, Figure 8A), immune score (p < 0.001, Figure 8B), and stromal score (p < 0.001, Figure 8C) compared with patients with low expression of SYCP2, which means that there were more tumor cells, immune cells, and stromal cells in the low-SYCP2 expression group than those in high-SYCP2 expression samples.